Boule Diagnostics

Boule Diagnostics is a diagnostic company specializing in the development, manufacturing, and marketing of systems and consumables for hematology. The company primarily serves the decentralized market segment, focusing on small and midsize hospitals, clinics, and laboratories within outpatient care, as well as other diagnostic firms in both human and veterinary hematology. Boule operates through commercial subsidiaries in Sweden, the United States, and China, and its products are distributed globally in over 100 countries. Founded in 1992 with the acquisition of Karo Bio Diagnostics AB, Boule's roots trace back to the 1950s when Erik Öhlin developed Europe’s first automatic blood cell counter. This legacy continues through the innovative instruments offered by Boule today.